Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2021-08-13 Investor Presentation
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA: Resultater for andre kvartal og første halvår 2021
Investor Presentation Classification · 99% confidence The document text explicitly states it contains 'First half and second quarter results 2021' and presents detailed financial tables for 'Q2 2021' and '1H 2021' (YTD 2021), including key figures like Revenue, EBITDA, and balance sheet items as of June 30, 2021. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year, specifically a half-year or quarterly report. The appendix mentions that the figures are not audited and the presentation uses the same measurement principles as the Annual Report 2019, confirming it is a periodic financial disclosure, not the full Annual Report (10-K). Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-08-13 Norwegian
Navamedic ASA: Resultater for andre kvartal og første halvår 2021
Earnings Release Classification · 98% confidence The document text explicitly states the content: "Navamedic ASA: Resultater for andre kvartal og første halvår 2021" (Results for the second quarter and first half of 2021). It provides key financial metrics (revenue, EBITDA) for the period and mentions an upcoming presentation. This structure—a summary of period results without being the full, detailed annual filing (10-K) or a standalone audit report (AR)—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it covers a specific interim period (Q2 and H1 2021) with detailed figures, it fits the definition of an Interim / Quarterly Report (IR) better than just the initial highlights (ER). However, the text also mentions an attached presentation and a webcast, suggesting it might be the press release accompanying the full report. Given the depth of the financial figures provided (NOK 66.0 million revenue, EBITDA figures, margin percentages), it leans towards being the comprehensive quarterly report summary itself, which aligns with the 'Interim / Quarterly Report' (IR) definition, rather than just the 'Earnings Release' (ER) which is usually just the highlights. The document is a detailed summary of the financial performance for the half-year/quarter. H1 2021
2021-08-13 Norwegian
Navamedic ASA: Invitation to 2021 Second quarter presentation
Report Publication Announcement Classification · 98% confidence The document is an explicit invitation to a presentation of the '2021 second quarter results' scheduled for a specific date and time, including details on location and webcast access. This is not the actual results document (which would likely be an ER or IR), nor is it a transcript (CT). It is an announcement about an upcoming event where results will be discussed. Since the definitions do not have a specific 'Earnings Call Invitation' code, the closest fit is a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were the actual release announcement. However, given the focus is purely on the *invitation* to the presentation, and it is very short (728 chars), it functions as a general regulatory announcement about an upcoming event related to financial reporting. RNS is the most appropriate fallback for event scheduling announcements that don't fit specific categories like DIV or DVA.
2021-08-10 English
Navamedic ASA ("Navamedic", OSE: NAVA) announces it has won the tender for certain antibiotics to the Norwegian hospital market
Regulatory Filings Classification · 95% confidence The document is a short announcement from Navamedic ASA regarding winning a tender for antibiotics in the Norwegian hospital market. It details the scope and duration of the contract (Feb 2022 to Feb 2024) and includes quotes from the CEO. This type of announcement, which is not a formal financial report (like 10-K or IR), nor a management change (MANG), nor a dividend notice (DIV), nor a director's dealing (DIRS), fits best under general regulatory announcements or news releases that impact business operations. Since it is a specific business development announcement that doesn't fit the other specialized categories (like M&A, Financing, Legal), it falls under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous official announcements, or potentially a general news release not explicitly covered. Given the options, RNS is the most appropriate catch-all for this type of market-moving, non-financial report news.
2021-06-17 English
Navamedic ASA: Minutes of Annual General Meeting
AGM Information Classification · 100% confidence The document text is explicitly titled 'PROTOKOLL FRA ORDINÆR GENERALFORSAMLING' (Minutes of Annual General Meeting) in Norwegian and 'MINUTES OF ANNUAL GENERAL MEETING' in English. It details the proceedings, resolutions passed (like election of meeting chair, approval of agenda, approval of annual accounts/report), and shareholder representation at the meeting held on June 3, 2021. This content directly corresponds to the documentation generated following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2021-06-03 Norwegian
Navamedic ASA: Minutes of Annual General Meeting
AGM Information Classification · 98% confidence The document title explicitly states 'Minutes of Annual General Meeting'. The text confirms the meeting took place and mentions that a copy of the minutes is attached. This directly corresponds to the definition of 'AGM Information' (Code: AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it is the minutes, it is material directly related to the AGM proceedings.
2021-06-03 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.